Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/B ratio high or low?
The P/B ratio of 0.56 is 71% below its estimated 4-year average of 1.94, near the low end of its estimated 4-year range (0.12–112.80).
As of 2026-10-06T15:27:46.267Z. 8.57% above its estimated 12-month average of 0.52.
Calculation as of: 2026-10-06T15:27:46.267Z.
Quote observation: 2026-10-06T15:25:25.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b762030de9532cd090a02a2f6ca20f5433f7bd8b112c678bdb57b8df4aeea120
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PB RATIO
0.56
PB RATIO AVG TTM
0.52
PB RATIO AVG 3Y
0.59
PB RATIO AVG 5Y
N/A
PB RATIO AVG 10Y
N/A
PB RATIO AVG 15Y
N/A
PB RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+8.57%
CURRENT VS 3Y AVG
-4.35%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.37
median of 592 covered companies
CURRENT VS SECTOR MEDIAN
-76.37%
vs the sector median at left
Market Cap
$7.24M
PB Ratio
1.51
TTM Avg
7.95
3Y Avg
41.49
5Y Avg
41.49
| NAME | MARKET CAP | PB RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mangoceuticals, Inc. (MGRX) | $6.98M | 0.56 | 0.52 | 0.59 | N/A |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $7.02M | N/A | 3.34 | 8.29 | 8.29 |
| Co-Diagnostics, Inc. (CODX)vs › | $7.13M | 0.56 | 0.28 | 0.33 | 0.65 |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.24M | 1.51 | 7.95 | 41.49 | 41.49 |
| KALA BIO, Inc. (KALA)vs › | $7.28M | 0.80 | 0.03 | 90.37 | 83.83 |
| Aclarion, Inc. (ACON)vs › | $6.66M | 0.39 | 0.26 | 15.14 | 21.12 |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | 6.80 | 0.84 | 0.41 | 0.43 |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.62M | 0.82 | 0.53 | 2.56 | 3.86 |
| Longeveron Inc. (LGVN)vs › | $7.43M | 0.71 | 1.64 | 1.68 | 2.89 |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.49M | 0.51 | 0.36 | 0.31 | 0.36 |
At 0.56, P/B is near its estimated 4-year median — higher than 44% of readings in its estimated 4-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 4-year low
0.12
median
0.65
estimated 4-year high
112.80
P/B Ratio
0.56
Market Price / Book Value per Share
PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)
The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PB RATIO |
|---|---|
| 2026-10-05 | 0.57 |
| 2026-10-02 | 0.60 |
| 2026-10-01 | 0.66 |
| 2026-09-30 | 0.59 |
| 2026-09-29 | 0.61 |
| 2026-09-28 | 0.53 |
| 2026-09-25 | 0.64 |
| 2026-09-24 | 0.63 |
| 2026-09-23 | 0.61 |
| 2026-09-22 | 0.59 |
| 2026-09-21 | 0.62 |
| 2026-09-18 | 0.65 |
| 2026-09-17 | 0.61 |
| 2026-09-16 | 0.62 |
| 2026-09-15 | 0.57 |
| 2026-09-14 | 0.56 |
| 2026-09-11 | 0.55 |
| 2026-09-10 | 0.53 |
| 2026-09-09 | 0.57 |
| 2026-09-08 | 0.56 |
| 2026-09-04 | 0.56 |
| 2026-09-03 | 0.53 |
| 2026-09-02 | 0.52 |
| 2026-09-01 | 0.53 |
| 2026-08-31 | 0.53 |
| 2026-08-28 | 0.55 |
| 2026-08-27 | 0.55 |
| 2026-08-26 | 0.51 |
| 2026-08-25 | 0.53 |
| 2026-08-24 | 0.52 |
| 2026-08-21 | 0.58 |
| 2026-08-20 | 0.53 |
| 2026-08-19 | 0.57 |
| 2026-08-18 | 0.64 |
| 2026-08-17 | 0.72 |
| 2026-08-14 | 0.73 |
| 2026-08-13 | 0.65 |
| 2026-08-12 | 0.65 |
| 2026-08-11 | 0.67 |
| 2026-08-10 | 0.73 |
| 2026-08-07 | 0.60 |
| 2026-08-06 | 0.64 |
| 2026-08-05 | 0.52 |
| 2026-08-04 | 0.56 |
| 2026-08-03 | 0.66 |
| 2026-07-31 | 0.68 |
| 2026-07-30 | 0.36 |
| 2026-07-29 | 0.68 |
| 2026-07-28 | 0.68 |
| 2026-07-27 | 0.66 |
| 2026-07-24 | 0.64 |
| 2026-07-23 | 0.68 |
| 2026-07-22 | 0.62 |
| 2026-07-21 | 0.58 |
| 2026-07-20 | 0.52 |
| 2026-07-17 | 0.50 |
| 2026-07-16 | 0.47 |
| 2026-07-15 | 0.46 |
| 2026-07-14 | 0.48 |
| 2026-07-13 | 0.44 |
| 2026-07-10 | 0.45 |
| 2026-07-09 | 0.46 |
| 2026-07-08 | 0.44 |
| 2026-07-07 | 0.46 |
| 2026-07-06 | 0.54 |
| 2026-07-02 | 0.57 |
| 2026-07-01 | 0.52 |
| 2026-06-30 | 0.46 |
| 2026-06-29 | 0.45 |
| 2026-06-26 | 0.46 |
| 2026-06-25 | 0.45 |
| 2026-06-24 | 0.44 |
| 2026-06-23 | 0.42 |
| 2026-06-22 | 0.36 |
| 2026-06-18 | 0.39 |
| 2026-06-17 | 0.41 |
| 2026-06-16 | 0.41 |
| 2026-06-15 | 0.44 |
| 2026-06-12 | 0.44 |
| 2026-06-11 | 0.45 |
| 2026-06-10 | 0.44 |
| 2026-06-09 | 0.42 |
| 2026-06-08 | 0.44 |
| 2026-06-05 | 0.44 |
| 2026-06-04 | 0.48 |
| 2026-06-03 | 0.46 |
| 2026-06-02 | 0.47 |
| 2026-06-01 | 0.51 |
| 2026-05-29 | 0.53 |
| 2026-05-28 | 0.59 |
| 2026-05-27 | 0.61 |
| 2026-05-26 | 0.67 |
| 2026-05-22 | 0.55 |
| 2026-05-21 | 0.54 |
| 2026-05-20 | 0.52 |
| 2026-05-19 | 0.43 |
| 2026-05-18 | 0.42 |
| 2026-05-15 | 0.46 |
| 2026-05-14 | 0.41 |
| 2026-05-13 | 0.36 |
| 2026-05-12 | 0.36 |
| 2026-05-11 | 0.44 |
| 2026-05-08 | 0.43 |
| 2026-05-07 | 0.36 |
| 2026-05-06 | 0.37 |
| 2026-05-05 | 0.33 |
| 2026-05-04 | 0.35 |
| 2026-05-01 | 0.33 |
| 2026-04-30 | 0.36 |
| 2026-04-29 | 0.35 |
| 2026-04-28 | 0.38 |
| 2026-04-27 | 0.42 |
| 2026-04-24 | 0.44 |
| 2026-04-23 | 0.42 |
| 2026-04-22 | 0.47 |
| 2026-04-21 | 0.49 |
| 2026-04-20 | 0.53 |
| 2026-04-17 | 0.46 |
| 2026-04-16 | 0.49 |
| 2026-04-15 | 0.42 |
| 2026-04-14 | 0.41 |
| 2026-04-13 | 0.41 |
| 2026-04-10 | 0.36 |
| 2026-04-09 | 0.36 |
| 2026-04-08 | 0.35 |
| 2026-04-07 | 0.39 |
| 2026-04-06 | 0.40 |
| 2026-04-02 | 0.35 |
| 2026-04-01 | 0.26 |
| 2026-03-31 | 0.26 |
| 2026-03-30 | 0.31 |
| 2026-03-27 | 0.36 |
| 2026-03-26 | 0.27 |
| 2026-03-25 | 0.24 |
| 2026-03-24 | 0.22 |
| 2026-03-23 | 0.24 |
| 2026-03-20 | 0.12 |
| 2026-03-19 | 0.26 |
| 2026-03-18 | 0.27 |
| 2026-03-17 | 0.29 |
| 2026-03-16 | 0.30 |
| 2026-03-13 | 0.28 |
| 2026-03-12 | 0.29 |
| 2026-03-11 | 0.28 |
| 2026-03-10 | 0.26 |
| 2026-03-09 | 0.25 |
| 2026-03-06 | 0.27 |
| 2026-03-05 | 0.27 |
| 2026-03-04 | 0.28 |
| 2026-03-03 | 0.30 |
| 2026-03-02 | 0.37 |
| 2026-02-27 | 0.39 |
| 2026-02-26 | 0.38 |
| 2026-02-25 | 0.37 |
| 2026-02-24 | 0.38 |
| 2026-02-23 | 0.40 |
| 2026-02-20 | 0.39 |
| 2026-02-19 | 0.26 |
| 2026-02-18 | 0.26 |
| 2026-02-17 | 0.28 |
| 2026-02-13 | 0.29 |
| 2026-02-12 | 0.29 |
| 2026-02-11 | 0.28 |
| 2026-02-10 | 0.28 |
| 2026-02-09 | 0.28 |
| 2026-02-06 | 0.28 |
| 2026-02-05 | 0.25 |
| 2026-02-04 | 0.26 |
| 2026-02-03 | 0.29 |
| 2026-02-02 | 0.31 |
| 2026-01-30 | 0.26 |
| 2026-01-29 | 0.28 |
| 2026-01-28 | 0.32 |
| 2026-01-27 | 0.33 |
| 2026-01-26 | 0.34 |
| 2026-01-23 | 0.38 |
| 2026-01-22 | 0.39 |
| 2026-01-21 | 0.40 |
| 2026-01-20 | 0.45 |
| 2026-01-16 | 0.46 |
| 2026-01-15 | 0.49 |
| 2026-01-14 | 0.50 |
| 2026-01-13 | 0.52 |
| 2026-01-12 | 0.58 |
| 2026-01-09 | 0.57 |
| 2026-01-08 | 0.73 |
| 2026-01-07 | 0.64 |
| 2026-01-06 | 0.64 |
| 2026-01-05 | 0.61 |
| 2026-01-02 | 0.63 |
| 2025-12-31 | 0.54 |
| 2025-12-30 | 0.48 |
| 2025-12-29 | 0.48 |
| 2025-12-26 | 0.52 |
| 2025-12-24 | 0.56 |
| 2025-12-23 | 0.57 |
| 2025-12-22 | 0.57 |
| 2025-12-19 | 0.52 |
| 2025-12-18 | 0.96 |
| 2025-12-17 | 0.89 |
| 2025-12-16 | 0.88 |
| 2025-12-15 | 0.84 |
| 2025-12-12 | 0.83 |
| 2025-12-11 | 0.83 |
| 2025-12-10 | 0.81 |
| 2025-12-09 | 0.89 |
| 2025-12-08 | 0.83 |
| 2025-12-05 | 0.81 |
| 2025-12-04 | 0.86 |
| 2025-12-03 | 0.90 |
| 2025-12-02 | 0.85 |
| 2025-12-01 | 0.73 |
| 2025-11-28 | 0.81 |
| 2025-11-26 | 0.78 |
| 2025-11-25 | 0.81 |
| 2025-11-24 | 0.84 |
| 2025-11-21 | 0.82 |
| 2025-11-20 | 0.84 |
| 2025-11-19 | 0.91 |
| 2025-11-18 | 0.94 |
| 2025-11-17 | 0.92 |
| 2025-11-14 | 0.77 |
| 2025-11-13 | 0.62 |
| 2025-11-12 | 0.91 |
| 2025-11-11 | 0.89 |
| 2025-11-10 | 1.08 |
| 2025-11-07 | 1.15 |
| 2025-11-06 | 0.95 |
| 2025-11-05 | 0.93 |
| 2025-11-04 | 0.93 |
| 2025-11-03 | 0.96 |
| 2025-10-31 | 1.08 |
| 2025-10-30 | 1.06 |
| 2025-10-29 | 1.13 |
| 2025-10-28 | 1.07 |
| 2025-10-27 | 1.11 |
| 2025-10-24 | 1.21 |
| 2025-10-23 | 1.20 |
| 2025-10-22 | 1.23 |
| 2025-10-21 | 1.42 |
| 2025-10-20 | 1.25 |
| 2025-10-17 | 1.24 |
| 2025-10-16 | 1.28 |
| 2025-10-15 | 1.32 |
| 2025-10-14 | 1.36 |
| 2025-10-13 | 1.31 |
| 2025-10-10 | 1.14 |
| 2025-10-09 | 1.13 |
| 2025-10-08 | 1.23 |
| 2025-10-07 | 1.25 |
| 2025-10-06 | 1.33 |
| 2025-10-03 | 1.18 |
| 2025-10-02 | 1.14 |
| 2025-10-01 | 1.09 |
| 2025-09-30 | 1.14 |
| 2025-09-29 | 1.09 |
| 2025-09-26 | 1.12 |
| 2025-09-25 | 1.17 |
| 2025-09-24 | 1.26 |
| 2025-09-23 | 1.18 |
Showing the most recent 260 of 827 data points. The chart above shows the full history.